{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-023525","form_type":"8-K","ticker":"PPCB","cik":"0001517681","company_name":"Propanc Biopharma, Inc.","filed_at":"2024-06-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:18.786181+00:00","generated_at":"2026-06-01T04:49:39.471015+00:00","sec_items":["1.01","2.03","3.02","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"Propanc Biopharma enters loans totaling $120K AUD at 12% interest","bullets":["First loan of $20,000 AUD on June 3, 2024, at 12% annual interest, maturing June 3, 2025.","Second loan of $100,000 AUD on June 5, 2024, at 12% annual interest, maturing June 5, 2025.","Proceeds used for general working capital; prepayment allowed without penalty.","Loans issued under Section 4(a)(2) private placement exemption."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-023525","json":"https://secwatch.observer/filing/0001493152-24-023525.json","markdown":"https://secwatch.observer/filing/0001493152-24-023525.md","text":"https://secwatch.observer/filing/0001493152-24-023525.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1517681/000149315224023525/0001493152-24-023525-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1517681/000149315224023525/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T04:49:39.471015+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}